Here are four observations:
1. A growing geriatric population, rising demand for minimally invasive surgery and increasing advancements of technologies will spur the SCS market growth.
2. Market barriers include the costliness of therapy as well as stringent regulatory approvals.
3. The market sees concentrated competition, with a few companies capturing large market shares.
4. Key market players include:
• Medtronic in Dublin, Ireland
• Nevro Corp. in Redwood City, Calif.
• Boston Scientific Corp. in Rolling Meadows, Ill.
• St. Jude Medical in Saint Paul, Minn.
More articles on devices:
Wisconsin’s Comprehensive Orthopaedics launches YouTube channel: 3 thoughts
Kator launches suture anchor system on a limited basis: 3 key notes
Dr. Nasser Ani uses SpineFrontier’s new minimally-invasive technology: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
